Trial Profile
Phase I exploratory pharmacokinetic (PK) clinical studies to assess the PK profiles both at over-the-counter (OTC) and prescription (Rx) strength doses of standard ibuprofen against OXPzero Ibuprofen.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Musculoskeletal pain
- Focus Pharmacokinetics
- 23 Nov 2016 New trial record